Tenascin-C Is Increased in Inflammatory Bowel Disease and Is Associated with response to Infliximab Therapy

Table 3

Relationship between Montreal classification and serum TNC levels.

	Number	Serum TNC (ng/L)	value
CD
Age at diagnosis			0.579
A1 (≤16)	4	44.9 (44.3, 60.5)
A2 (17–20)	54	57.0 (43.9, 79.1)
A3(>40)	33	61.2 (45.6, 89.0)
Location			0.916
L1	22	55.1 (48.8, 79.4)
L2	30	65.6 (42.5, 89.0)
L3	39	57.0 (44.7, 78.4)
L4	0	−
Disease behavior			0.278
B1	51	57.0 (45.0, 81.2)
B2	16	56.4 (38.6, 70.9)
B3	24	68.5 (46.1, 87.8)
UC
Disease extension			0.729
E1	3	59.3 (54.2, 83.8)
E2	13	71.1 (33.3, 102.4)
E3	24	77.8 (48.8, 100.1)

CD, Crohn’s disease; UC, ulcerative colitis.